The annual societal cost of Parkinson’s disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, a new study published today in Movement Disorders has shown. As the number of people living with Parkinson’s disease continues to grow, researchers warn that health and social care systems are likely to face increasing pressure.
The research estimated that approximately 2.2 million adults were living with Parkinson’s disease across 47 European countries in 2019. The condition resulted in €17.3 billion of direct medical and non-medical costs, €4.4 billion in unpaid informal care provided by family members and friends and a further €1 billion in indirect costs due to lost productivity.
Parkinson’s disease is the world’s second most common and fastest-growing neurodegenerative disorder. Its prevalence in Europe has nearly…
